Key result
MitraClip improves symptoms and quality of life in a frail octogenarian with severe primary MR.
Why the study?
Percutaneous mitral valve repair is an accepted treatment for severe mitral regurgitation in high surgical risk patients, but its use in India had not been reported.
Does MitraClip improve symptoms and quality of life in a high-risk elderly patient with severe primary mitral regurgitation?
Case Report (n=1)
No
Does MitraClip improve symptoms and quality of life in a high-risk elderly patient with severe primary mitral regurgitation?
This case report describes the first successful use of MitraClip in India, demonstrating symptomatic and quality of life improvements in a high-risk elderly patient with severe primary mitral regurgitation.
May support MitraClip in frail octogenarians with primary MR; hypothesis-generating and requires prospective validation before practice change.
Percutaneous mitral valve repair is an accepted treatment of choice in Europe and North America for severe primary or secondary mitral regurgitation, in highly symptomatic patients for whom surgical repair is prohibitively high risk. We describe the first use of the MitraClip in India in a frail elderly female with symptomatic heart failure from severe primary mitral regurgitation who was considered high risk for surgical repair. She had substantial improvement in her symptoms as well as quality of life following the procedure.
No takes yet. Share an insight, caveat, or question.
Chandrasekaran et al. (2020) conducted a case report in Symptomatic heart failure from severe primary mitral regurgitation (n=1). MitraClip was evaluated on Symptoms and quality of life. Percutaneous mitral valve repair using MitraClip resulted in substantial improvement in symptoms and quality of life in a frail octogenarian female with severe primary mitral regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: